Archives

by in
Entry Author Date Location
FDA Staff Issues Positive Report for Aegerion’s Lomatapide 10/15/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
How Lilly Let Telaprevir Go to Vertex, SV Focusing on Health IT With Latest Fund, Genzyme Isis Cholesterol Drug Shows Strong in Clinical Trial, & More Boston-Area Life Sciences News 08/06/10 Boston
Genzyme, Isis Cholesterol Drug Passes Pair of Clinical Trials; Shares Fall Anyway 08/04/10 Boston
SonoSite’s New Push: Ultrasound for an Up-Close Look at Heart Attack Risk 07/26/10 Seattle
Lessons Learned About the Outlook for New Obesity Drug Approval 07/16/10 National
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News 03/11/10 San Diego
Isis Nabs $6M Bristol Payment 03/08/10 San Diego
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety 11/17/09 San Diego
Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance 10/21/09 San Diego
Oscient Pharma Seeks Bankruptcy, Finds Buyer for No. 2 Product 07/14/09 Boston
Genzyme, Isis Cholesterol Drug Reaches Goal in Pivotal Study, Paving the Way to FDA 05/20/09 Boston
Genzyme, Isis Begin New Drug Trials 01/12/09 Boston
Genzyme Thinks Small, and Big, With Cholesterol-Lowering Drug Mipomersen 09/29/08 Boston
Genzyme, Isis Start Pivotal Trial for High Cholesterol 08/06/08 Boston
MediQuest Therapeutics Persuades FDA to Do 6-Month Review of Lead Product 06/25/08 Seattle
Genzyme, Isis Finalize Partnership For Cholesterol-Lowering Drug 06/24/08 Boston
Page 1 of 1

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.